Autus Asset Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
$525K Hold
1,434
0.09% 104
2022
Q3
$464K Sell
1,434
-4
-0.3% -$1.27K 0.09% 105
2022
Q2
$466K Sell
1,438
-15
-1% -$4.5K 0.08% 105
2022
Q1
$416K Sell
1,453
-38
-3% -$9.78K 0.06% 114
2021
Q4
$412K Sell
1,491
-25
-2% -$6.34K 0.04% 135
2021
Q3
$350K Buy
+1,516
New +$374K 0.04% 136
2021
Q2
Sell
-1,166
Closed -$218K 170
2021
Q1
$218K Buy
+1,166
New +$228K 0.03% 159

Other funds holding LLY

Autus Asset Management's LLY Position: Q4 2022 in Review

Autus Asset Management held its Eli Lilly (LLY) position steady in Q4 2022 at 1,434 shares worth $525K. The position accounts for 0.09% of the portfolio, ranked #104.

Autus Asset Management first reported a position in LLY in Q1 2021 and has held it in 7 quarters since. 2,671 funds tracked by Wall St. Rank hold LLY as of Q4 2022.

  • Autus Asset Management held 1,434 shares of Eli Lilly worth $525K as of Q4 2022.
  • Autus Asset Management left its Eli Lilly share count unchanged in Q4 2022.
  • Eli Lilly made up 0.09% of Autus Asset Management's portfolio in Q4 2022, its #104 holding.
  • Autus Asset Management first reported a position in Eli Lilly in Q1 2021 and has held it in 7 quarters since.
  • 2,671 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2022.

Based on Autus Asset Management's 13F filing for Q4 2022, filed 24 Jan 2023.